Senores Pharmaceuticals bulk deals, insider trading and stake changes
NSE: SENORESBSE: 544319Pharmaceuticals & BiotechnologySmall Cap
Last close ₹1,215.30up ₹12.70 (1.06%)BSE ₹1,213.90
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,202.60.
52-week range of traded prices to 23 Oct 2026
₹706.00Low, 23 Mar 2026₹1,599.00High, 24 Aug 2026
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹5,597 Cr841st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 27 Jul 2026
- 42.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 6.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 27 Jul 2026
- 15.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 27 Jul 2026
- 13.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.34
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,65,74443.3% delivered
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Senores Pharmaceuticals promoter holding
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group2 purchases, 0 sales₹0.82 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹0.82 Cr2 pledges created · 1 pledge released · 2 pledge filings of unclear kind · 7 off-market moves
- Employees1 purchase, 0 sales₹0.02 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹0.02 Cr
- Others4 purchases, 0 sales₹0.07 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹0.07 Cr1 pledge filing of unclear kind
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Senores Pharmaceuticals insider trading
The latest 100 of 104 disclosures on record.Insider trading, all companies
Aug 2026
- Ashokbhai Vijaysinh Barot₹4.54 Cr30,000 sharesBought · Promoter And Designated Person · 20 Aug 2026 · disclosed 30 Sep
- Dhananjay A. Barot₹4.54 Cr30,000 sharesSold or invoked · Promoter · 20 Aug 2026 · disclosed 30 Sep
- DHANANJAY ASHOKKUMAR BAROT30,000sharesGave · Promoter Group · 10 Aug 2026 · disclosed 12 Aug · Off Market · stake 0.68% before, 0.62% after
- ASHOKKUMAR VIJAYSINH BAROT30,000sharesReceived · Promoter · 10 Aug 2026 · disclosed 12 Aug · Off Market · stake 7.48% before, 7.55% after
Jun 2026
- Mukurdhvaj Yogeshkumar Barot₹25 Cr1,93,000 sharesPledge · Promoter · 29 Jun 2026 · disclosed 3 Jul
Mar 2026
- Ashokbhai Vijaysinh Barot₹9.99 Cr1,23,000 unitsReceived · Promoters · 28 Mar 2026 · Warrants · disclosed 1 Apr · Others · holds 1,23,000 after
- Swapnil Jatin Shah₹16 Cr1,97,000 unitsReceived · Promoters · 28 Mar 2026 · Warrants · disclosed 1 Apr · Others · holds 1,97,000 after
- Renosen Pharmaceuticals Private Limited₹60 Cr7,39,000 unitsReceived · Promoter Group · 28 Mar 2026 · Warrants · disclosed 1 Apr · Others · holds 7,39,000 after
- Viraj Ashokkumar Barot₹4.02 Cr49,500 unitsReceived · Promoter Group · 28 Mar 2026 · Warrants · disclosed 1 Apr · Others · holds 49,500 after
- Sangeeta Mukur Barot₹4.99 Cr61,500 unitsReceived · Promoter Group · 28 Mar 2026 · Warrants · disclosed 1 Apr · Others · holds 61,500 after
Feb 2026
- Dhruvalben Vishal Shah₹0.03 Cr350 sharesBought · Other · 24 Feb 2026 · disclosed 26 Feb · held 650 before, holds 1,000 after
- Renosen Pharmaceuticals Private Limited₹33 Cr4,00,000 sharesSold or invoked · Promoter · 18 Feb 2026 · disclosed 7 Apr
- Renosen Pharmaceuticals Private Limited₹33 Cr4,00,000 sharesBought · Promoter · 18 Feb 2026 · disclosed 7 Apr
- Espee Therapeutics LLP₹31 Cr4,00,000 sharesPledged · Promoter Group · 13 Feb 2026 · disclosed 17 Feb · Pledge Creation · stake 1.07% before, 1.07% after
- Renosen Pharmaceuticals Private Limited₹31 Cr4,00,000 sharesReleased · Promoter Group · 13 Feb 2026 · disclosed 16 Feb · Revokation of Pledge · stake 5.90% before, 5.90% after
- Espee Therapeutics LLP₹33 Cr4,00,000 sharesPledge · Promoter · 11 Feb 2026 · disclosed 7 Apr
Jan 2026
- Sangeeta Mukur Barot₹86 Cr10,42,955 sharesBought · Promoter · 8 Jan 2026 · disclosed 6 Apr
- Swapnil Jatinbhai Shah₹292 Cr35,53,531 sharesSold or invoked · Promoter And Designated Person · 8 Jan 2026 · disclosed 6 Apr
- Sangeeta Mukur Barot₹86 Cr10,42,955 sharesSold or invoked · Promoter · 8 Jan 2026 · disclosed 6 Apr
- Renosen Pharmaceuticals Private Limited₹190 Cr23,18,719 sharesBought · Promoter · 8 Jan 2026 · disclosed 6 Apr
- Ashokbhai Vijaysinh Barot₹283 Cr34,44,869 sharesBought · Promoter And Designated Person · 8 Jan 2026 · disclosed 6 Apr
- Ashokbhai Vijaysinh Barot₹283 Cr34,44,869 sharesSold or invoked · Promoter And Designated Person · 8 Jan 2026 · disclosed 6 Apr
- Renosen Pharmaceuticals Private Limited₹190 Cr23,18,719 sharesSold or invoked · Promoter · 8 Jan 2026 · disclosed 6 Apr
- Swapnil Jatinbhai Shah₹292 Cr35,53,531 sharesBought · Promoter And Designated Person · 8 Jan 2026 · disclosed 6 Apr
Dec 2025
- Renosen Pharmaceuticals Private Limited₹0.49 Cr6,000 sharesBought · Promoter Group · 31 Dec 2025 · disclosed 1 Jan 2026 · stake 5.89% before, 5.90% after
- Renosen Pharmaceuticals Private Limited₹0.32 Cr4,000 sharesBought · Promoter Group · 17 Dec 2025 · disclosed 18 Dec · stake 5.88% before, 5.89% after
- Dhruvalben Vishal Shah₹0.01 Cr150 sharesBought · Other · 11 Dec 2025 · disclosed 15 Dec · held 400 before, holds 550 after
- Vinodkumar Gandalal Shah₹0.02 Cr300 sharesBought · Other · 10 Dec 2025 · disclosed 12 Dec · held 1,350 before, holds 1,650 after
- Vinodkumar Gandalal Shah₹78,314100 sharesBought · Other · 10 Dec 2025 · disclosed 12 Dec · held 1,250 before, holds 1,350 after
- Renosen Pharmaceuticals Private Limited₹30 Cr4,00,000 sharesPledged · Promoter Group · 3 Dec 2025 · disclosed 4 Dec · Pledge Creation · stake 5.88% before, 5.88% after
Earlier, Feb 2025 to Nov 2025Hide earlier
Nov 2025
- Kalpit Rajesh Gandhi₹1.53 Cr20,000 sharesPledge · Designated Person · 25 Nov 2025 · disclosed 27 Nov
- Pratik Sureshkumar Thakkar₹0.02 Cr200 sharesBought · Employees/Designated Employees · 14 Nov 2025 · disclosed 17 Nov · stake 0.01% before, 0.01% after
Sep 2025
- Pratik Sureshkumar Thakkar HUF₹0.02 Cr350 sharesBought · Other · 12 Sep 2025 · disclosed 13 Sep · held 400 before, holds 750 after
- Chetan Bipinchandra Shah₹0.04 Cr500 sharesBought · Director · 10 Sep 2025 · disclosed 12 Sep · stake 0.01% before, 0.01% after
Aug 2025
- Ashokbhai Vijaysinh Barot₹0.07 Cr1,000 sharesBought · Promoters · 28 Aug 2025 · disclosed 29 Aug · stake 7.48% before, 7.48% after
- Renosen Pharmaceuticals Private Limited₹0.17 Cr2,500 sharesBought · Promoter Group · 28 Aug 2025 · stake 5.88% before, 5.88% after
- Ashokbhai Vijaysinh Barot₹1.16 Cr16,089 sharesBought · Promoter And Designated Person · 22 Aug 2025 · disclosed 26 Aug
- Ashokbhai Vijaysinh Barot₹1.17 Cr16,086 sharesBought · Promoters · 22 Aug 2025 · stake 7.44% before, 7.48% after
- Renosen Pharmaceuticals Private Limited₹0.07 Cr1,000 sharesBought · Promoter Group · 21 Aug 2025 · disclosed 22 Aug · stake 5.87% before, 5.88% after
- Dhananjay Ashokkumar Barot₹0.36 Cr5,111 sharesSold · Promoter Group · 20 Aug 2025 · disclosed 22 Aug · stake 0.69% before, 0.68% after
- Dhananjay Ashokkumar Barot₹0.50 Cr7,100 sharesSold · Promoter Group · 19 Aug 2025 · disclosed 22 Aug · stake 0.71% before, 0.69% after
- Dhananjay Ashokkumar Barot₹0.35 Cr5,100 sharesSold · Promoter Group · 18 Aug 2025 · disclosed 22 Aug · stake 0.72% before, 0.71% after
Jul 2025
- Amee Chetan Shah₹0.02 Cr300 sharesBought · Immediate relative · 28 Jul 2025 · disclosed 31 Jul · held 200 before, holds 500 after
- Renosen Pharmaceuticals Private Limited₹0.19 Cr3,000 sharesBought · Promoter Group · 28 Jul 2025 · stake 5.87% before, 5.87% after
- Chetan Bipinchandra Shah₹0.03 Cr500 sharesBought · Director · 28 Jul 2025 · disclosed 29 Jul · stake 0.01% before, 0.01% after
May 2025
- Renosen Pharmaceuticals Private Limited₹0.20 Cr4,000 sharesBought · Promoter Group · 26 May 2025 · disclosed 28 May · stake 5.86% before, 5.87% after
Mar 2025
- Chetan Bipinchandra Shah₹0.03 Cr550 sharesBought · Director · 12 Mar 2025 · disclosed 13 Mar · held 3,000 before, holds 3,550 after, stake 0.01% after
Feb 2025
- Chetan Bipinchandra Shah₹0.06 Cr1,000 sharesBought · Director · 25 Feb 2025 · disclosed 27 Feb · held 2,000 before, holds 3,000 after
- Chetan Bipinchandra Shah₹0.06 Cr1,000 sharesBought · Director · 24 Feb 2025 · disclosed 27 Feb · held 1,000 before, holds 2,000 after
- Chetan Bipinchandra Shah₹0.02 Cr298 sharesBought · Director · 19 Feb 2025 · disclosed 21 Feb · held 224 before, holds 522 after
- Chetan Bipinchandra Shah₹17,73634 sharesBought · Director · 19 Feb 2025 · disclosed 21 Feb · held 150 before, holds 184 after
- Chetan Bipinchandra Shah₹5211 sharesBought · Director · 19 Feb 2025 · disclosed 21 Feb · held 184 before, holds 185 after
- Chetan Bipinchandra Shah₹15,13229 sharesBought · Director · 19 Feb 2025 · disclosed 21 Feb · held 185 before, holds 214 after
- Chetan Bipinchandra Shah₹5,21810 sharesBought · Director · 19 Feb 2025 · disclosed 21 Feb · held 214 before, holds 224 after
- Chetan Bipinchandra Shah₹10,44120 sharesBought · Director · 19 Feb 2025 · disclosed 21 Feb · held 522 before, holds 542 after
- Chetan Bipinchandra Shah₹12,00823 sharesBought · Director · 19 Feb 2025 · disclosed 21 Feb · held 542 before, holds 565 after
- Chetan Bipinchandra Shah₹49,60495 sharesBought · Director · 19 Feb 2025 · disclosed 21 Feb · held 565 before, holds 660 after
- Chetan Bipinchandra Shah₹19,32137 sharesBought · Director · 19 Feb 2025 · disclosed 21 Feb · held 660 before, holds 697 after
- Chetan Bipinchandra Shah₹39,69176 sharesBought · Director · 19 Feb 2025 · disclosed 21 Feb · held 697 before, holds 773 after
- Chetan Bipinchandra Shah₹24,02546 sharesBought · Director · 19 Feb 2025 · disclosed 21 Feb · held 773 before, holds 819 after
- Chetan Bipinchandra Shah₹12,01423 sharesBought · Director · 19 Feb 2025 · disclosed 21 Feb · held 819 before, holds 842 after
- Chetan Bipinchandra Shah₹74,181142 sharesBought · Director · 19 Feb 2025 · disclosed 21 Feb · held 842 before, holds 984 after
- Chetan Bipinchandra Shah₹8,35916 sharesBought · Director · 19 Feb 2025 · disclosed 21 Feb · held 984 before, holds 1,000 after
- Sanjay Shaileshbhai Majmudar₹0.03 Cr527 sharesBought · Director · 13 Feb 2025 · held 130 before, holds 657 after
- Sanjay Shaileshbhai Majmudar₹17,37232 sharesBought · Director · 13 Feb 2025 · held 40 before, holds 72 after
- Sanjay Shaileshbhai Majmudar₹20,62838 sharesBought · Director · 13 Feb 2025 · held 2 before, holds 40 after
- Sanjay Shaileshbhai Majmudar₹5421 sharesBought · Director · 13 Feb 2025 · held 1 before, holds 2 after
- Sanjay Shaileshbhai Majmudar₹31,49158 sharesBought · Director · 13 Feb 2025 · held 72 before, holds 130 after
- Sanjay Shaileshbhai Majmudar₹5421 sharesBought · Director · 13 Feb 2025 · holds 1 after
- Sanjay Shaileshbhai Majmudar₹20,98938 sharesBought · Director · 13 Feb 2025 · held 1,859 before, holds 1,897 after
- Sanjay Shaileshbhai Majmudar₹5,52410 sharesBought · Director · 13 Feb 2025 · held 1,849 before, holds 1,859 after
- Sanjay Shaileshbhai Majmudar₹0.02 Cr398 sharesBought · Director · 13 Feb 2025 · held 1,451 before, holds 1,849 after
- Sanjay Shaileshbhai Majmudar₹71,825130 sharesBought · Director · 13 Feb 2025 · stake 0.01% before, 0.01% after
- Sanjay Shaileshbhai Majmudar₹82,233149 sharesBought · Director · 13 Feb 2025 · stake 0.01% before, 0.01% after
- Sanjay Shaileshbhai Majmudar₹0.02 Cr368 sharesBought · Director · 13 Feb 2025 · stake 0.01% before, 0.01% after
- Sanjay Shaileshbhai Majmudar₹12,69623 sharesBought · Director · 13 Feb 2025 · stake 0.01% before, 0.01% after
- Sanjay Shaileshbhai Majmudar₹24,84245 sharesBought · Director · 13 Feb 2025 · held 2,285 before, holds 2,330 after, stake 0.01% after
- Sanjay Shaileshbhai Majmudar₹33,68161 sharesBought · Director · 13 Feb 2025 · held 2,224 before, holds 2,285 after
- Sanjay Shaileshbhai Majmudar₹35,89365 sharesBought · Director · 13 Feb 2025 · held 2,159 before, holds 2,224 after
- Sanjay Shaileshbhai Majmudar₹45,28482 sharesBought · Director · 13 Feb 2025 · held 2,077 before, holds 2,159 after
- Sanjay Shaileshbhai Majmudar₹99,414180 sharesBought · Director · 13 Feb 2025 · held 1,897 before, holds 2,077 after
- Sanjay Shaileshbhai Majmudar₹0.02 Cr317 sharesBought · Director · 13 Feb 2025 · held 1,134 before, holds 1,451 after
- Sanjay Shaileshbhai Majmudar₹5511 sharesBought · Director · 13 Feb 2025 · held 1,133 before, holds 1,134 after
- Sanjay Shaileshbhai Majmudar₹0.03 Cr454 sharesBought · Director · 13 Feb 2025 · held 679 before, holds 1,133 after
- Jeshika Hiten Parikh₹0.01 Cr270 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 153 before, holds 423 after
- Jeshika Hiten Parikh₹15,82330 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 123 before, holds 153 after
- Jeshika Hiten Parikh₹38,50073 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 50 before, holds 123 after
- Jeshika Hiten Parikh₹9,49218 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 32 before, holds 50 after
- Jeshika Hiten Parikh₹8,43716 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 16 before, holds 32 after
- Jeshika Hiten Parikh₹32,25361 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 1,857 before, holds 1,918 after
- Jeshika Hiten Parikh₹14,27727 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 1,830 before, holds 1,857 after
- Jeshika Hiten Parikh₹2,1154 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 1,826 before, holds 1,830 after
- Jeshika Hiten Parikh₹33,32063 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 1,763 before, holds 1,826 after
- Jeshika Hiten Parikh₹0.02 Cr289 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 1,474 before, holds 1,763 after
- Jeshika Hiten Parikh₹0.05 Cr922 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 552 before, holds 1,474 after
- Jeshika Hiten Parikh₹8,44016 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · holds 16 after
- Jeshika Hiten Parikh₹43,37882 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 1,918 before, holds 2,000 after
- Jeshika Hiten Parikh₹5281 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 551 before, holds 552 after
- Jeshika Hiten Parikh₹65,596124 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 427 before, holds 551 after
- Jeshika Hiten Parikh₹2,1094 sharesBought · Other · 12 Feb 2025 · disclosed 14 Feb · held 423 before, holds 427 after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Senores Pharmaceuticals stake sales and purchases
All 19 disclosures on record.
Aug 2026
- AcquiredAshokkumar Vijaysinh Barot · promoter0.06% of the company30,000 sharesholds 7.55% after10 Aug 2026 · filed under the 2% rule · Inter-se transfer
- AcquiredAshokkumar Vijaysinh Barot · promoterholds 0.27% after10 Aug 2026 · filed under the 2% rule · Inter-se transfer
- SoldDhananjay Ashokkumar Barot · promoter0.06% of the company30,000 sharesholds 0.62% after10 Aug 2026 · filed under the 2% rule · Inter-se transfer
Mar 2026
- AcquiredAshokbhai Vijaysinh Barot · promoter1,23,000 sharesholds 35,67,869 shares after28 Mar 2026 · filed under the 2% rule
- AcquiredRenosen Pharmaceuticals Private Limited · promoter7,39,000 sharesholds 34,57,719 shares after28 Mar 2026 · filed under the 2% rule
- AcquiredSwapnil Jatin Shah · promoter1,97,000 sharesholds 37,50,531 shares after28 Mar 2026 · filed under the 2% rule
- AcquiredViraj Ashokkumar Barot · promoter49,500 sharesholds 49,500 shares after28 Mar 2026 · filed under the 2% rule
- AcquiredSangeeta Mukur Barot · promoter61,500 sharesholds 11,04,455 shares after28 Mar 2026 · filed under the 2% rule
Dec 2025
- AcquiredRenosen Pharmaceuticals Private Limited · promoter0.01% of the company6,000 sharesholds 5.90% after31 Dec 2025 · filed under the 2% rule · Open Market
- AcquiredRenosen Pharmaceuticals Private Limited · promoter0.01% of the company4,000 sharesholds 5.89% after17 Dec 2025 · filed under the 2% rule · Open Market
Aug 2025
- AcquiredAshokkumar Vijaysinh Barot · promoter1,000 sharesholds 7.48% after28 Aug 2025 · filed under the 2% rule · Open Market
- AcquiredRenosen Pharmaceuticals Private Limited · promoter2,500 sharesholds 5.88% after28 Aug 2025 · filed under the 2% rule · Open Market
- AcquiredAshokkumar Vijaysinh Barot · promoter0.04% of the company16,086 sharesholds 7.48% after22 Aug 2025 · filed under the 2% rule · Open Market
- AcquiredRenosen Pharmaceuticals Private Limited · promoter1,000 sharesholds 5.88% after21 Aug 2025 · filed under the 2% rule · Open Market
- SoldDhananjay Ashokkumar Barot · promoter0.01% of the company5,111 sharesholds 0.68% after20 Aug 2025 · filed under the 2% rule · Open Market
- SoldDhananjay Ashokkumar Barot · promoter0.02% of the company7,100 sharesholds 0.69% after19 Aug 2025 · filed under the 2% rule · Open Market
- SoldDhananjay Ashokkumar Barot · promoter0.01% of the company5,100 sharesholds 0.71% after18 Aug 2025 · filed under the 2% rule · Open Market
Jul 2025
- AcquiredRenosen Pharmaceuticals Private Limited · promoter0.01% of the company3,000 sharesholds 5.87% after28 Jul 2025 · filed under the 2% rule · Open Market
May 2025
- AcquiredRenosen Pharmaceuticals Private Limited · promoter0.01% of the company4,000 sharesholds 5.87% after26 May 2025 · filed under the 2% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Senores Pharmaceuticals bulk deals
Last 12 months, since 23 Oct 2025: 3 bulk deals, none bought and ₹85 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Wednesday 24 Dec 20253 firms · ₹0 bought · ₹85 Cr soldNet sold ₹85 Cr
- SoldASTORNE CAPITAL VCC ARVENSold 5,00,000 at ₹792.121.09% of the company₹40 Cr
- SoldRAVI PAWANKUMAR SANGHVISold 2,92,500 at ₹792.190.64% of the company₹23 Cr
- SoldYASHKUMAR SHANTILAL SANGHVISold 2,76,270 at ₹792.000.60% of the company₹22 Cr
Tuesday 29 Jul 20252 firms · ₹40 Cr bought · ₹38 Cr soldNet bought ₹2.12 Cr
- Both waysHRTI PRIVATE LIMITEDBought 2,69,264 at ₹686.66Sold 2,37,321 at ₹688.870.58% of the companyNet +31,943 shares₹18 Cr bought
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 3,16,091 at ₹689.33Sold 3,16,091 at ₹689.980.69% of the companyNet nil₹22 Cr bought
Thursday 24 Jul 20252 firms · ₹61 Cr bought · ₹61 Cr soldNet sold ₹0.23 Cr
- Both waysQE SECURITIES LLPBought 2,44,396 at ₹686.01Sold 2,47,903 at ₹684.180.54% of the companyNet −3,507 shares₹17 Cr bought
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 6,39,285 at ₹684.96Sold 6,39,285 at ₹685.441.39% of the companyNet nil₹44 Cr bought
Wednesday 19 Mar 20251 firm · ₹15 Cr bought · ₹15 Cr soldNet bought ₹0.02 Cr
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 2,37,696 at ₹635.98Sold 2,37,696 at ₹634.950.52% of the companyNet nil₹15 Cr bought
Thursday 6 Feb 20253 firms · ₹52 Cr bought · ₹52 Cr soldNet bought ₹0.59 Cr
- Both waysHRTI PRIVATE LIMITEDBought 2,97,095 at ₹617.65Sold 2,53,860 at ₹609.760.65% of the companyNet +43,235 shares₹18 Cr bought
- Both waysQE SECURITIES LLPBought 2,46,061 at ₹609.01Sold 2,80,836 at ₹612.490.61% of the companyNet −34,775 shares₹15 Cr bought
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 3,11,829 at ₹606.92Sold 3,11,829 at ₹609.000.68% of the companyNet nil₹19 Cr bought
Friday 24 Jan 20251 firm · ₹14 Cr bought · ₹14 Cr soldNet nil
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 2,49,581 at ₹565.43Sold 2,49,581 at ₹565.300.54% of the companyNet nil₹14 Cr bought
Thursday 23 Jan 20252 firms · ₹28 Cr bought · ₹26 Cr soldNet bought ₹2.69 Cr
- Both waysHRTI PRIVATE LIMITEDBought 2,31,641 at ₹551.72Sold 1,83,590 at ₹548.300.50% of the companyNet +48,051 shares₹13 Cr bought
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 2,83,905 at ₹550.54Sold 2,83,905 at ₹551.240.62% of the companyNet nil₹16 Cr bought
Tuesday 31 Dec 20241 firm · ₹15 Cr bought · ₹14 Cr soldNet bought ₹76,906
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 2,56,353 at ₹565.80Sold 2,56,353 at ₹565.500.56% of the companyNet nil₹15 Cr bought
Monday 30 Dec 20248 firms · ₹186 Cr bought · ₹161 Cr soldNet bought ₹25 Cr
- BoughtINDIA EQUITY FUND 1Bought 3,10,500 at ₹579.890.67% of the company₹18 Cr
- Both waysMANSI SHARE AND STOCK ADVISORS PVT LTDBought 3,02,592 at ₹595.33Sold 1,97,438 at ₹558.540.66% of the companyNet +1,05,154 shares₹18 Cr bought
- Both waysMARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITEDBought 6,70,880 at ₹561.73Sold 6,70,880 at ₹563.381.46% of the companyNet nil₹38 Cr bought
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 2,38,184 at ₹579.39Sold 2,38,184 at ₹580.060.52% of the companyNet nil₹14 Cr bought
- Both waysGRT STRATEGIC VENTURES LLPBought 4,80,801 at ₹582.51Sold 4,80,801 at ₹582.831.04% of the companyNet nil₹28 Cr bought
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 5,52,678 at ₹583.57Sold 5,52,678 at ₹583.811.20% of the companyNet nil₹32 Cr bought
- Both waysIRAGE BROKING SERVICES LLPBought 4,07,260 at ₹574.11Sold 4,07,260 at ₹574.430.88% of the companyNet nil₹23 Cr bought
- Both waysSMC GLOBAL SECURITIES LIMITEDBought 2,53,495 at ₹587.36Sold 2,53,495 at ₹587.640.55% of the companyNet nil₹15 Cr bought
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 44 deals on record since listing on 30 Dec 2024.